Our expert for hiPSC-derived cardiac cells, as well as cell-based assays & services for drug safety and efficacy screenings
Maximize valuable staffing resources and processing time by taking advantage of our convenient CardioPlate™ format.
CardioPlate™ eliminates the risk of interpersonal variations in preparing cardiomyocytes for use in assays and maximizes valuable staffing resources and processing time. You benefit from our stem cell expertise and optimized processes for reproducible production of high-quality CardioPlate™ products. This ensures a high-level of consistency at your site. Handling of CardioPlate™ products requires no expertise in thawing and seeding of hiPSC-derived cardiomyocytes, and a media change is all that's needed before use. Each CardioPlate™ is quality-controlled and thoroughly validated for the designated application.
Easy to use
ready for assay within 1 day after delivery
cells arrive pre-plated and ready-to-use in your lab, no extensive cell culture is required
optimized for the designated assay
standardized plates, large batch sizes possible
guaranteed by strict quality-controlled manufacturing and QC release
CardioPlates™ are hiPSC-derived cardiomyocytes in a convenient plate formats, ready-to-use in downstream assays. They are shipped and delivered at 37°C.
The Cor.4U, vCor.4U and FibroCor.4U and Cor.4U CardioPlate products have been discontinued. Please address questions to email@example.com or contact your local Ncardia sales representative.